Skip to main content
Figure 1 | Experimental Hematology & Oncology

Figure 1

From: Demographic, clinical, pathological, molecular, treatment characteristics and outcomes of nonmetastatic inflammatory breast cancer in Morocco: 2007 and 2008

Figure 1

The figure below shows the outcomes of nonmetastatic IBC in Morocco (A, B and C), the prognostic factors (D, E, F and G) and the impact of molecular subtypes (H). A: LRRFS probability in nonmetastatic IBC patients; B: EFS probability in nonmetastatic IBC patients; C: OS probability in nonmetastatic IBC patients; D: Positive effect of ER-positive status in EFS; E: Positive impact of RT in LRRFS; F: Positive impact of RT in EFS; G: Positive impact of RT in OS; H: Survival according to molecular subtypes.

Back to article page